European Journal of Cancer
Volume 42, Issue 1 , Pages 42-49, January 2006

Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?

  • Fabio Efficace

      Affiliations

    • European Organisation for Research and Treatment of Cancer (EORTC), EORTC Data Center, Quality of Life Unit, Avenue E. Mounier, 83, 1200 Brussels, Belgium
    • Corresponding Author InformationCorresponding author: Tel.: +32 2 774 1680; fax: +32 2 779 4568.
  • ,
  • Andrew Bottomley

      Affiliations

    • European Organisation for Research and Treatment of Cancer (EORTC), EORTC Data Center, Quality of Life Unit, Avenue E. Mounier, 83, 1200 Brussels, Belgium
  • ,
  • Corneel Coens

      Affiliations

    • European Organisation for Research and Treatment of Cancer (EORTC), EORTC Data Center, Quality of Life Unit, Avenue E. Mounier, 83, 1200 Brussels, Belgium
  • ,
  • Kristel Van Steen

      Affiliations

    • Harvard School of Public Health, Department of Biostatistics, Boston, USA
  • ,
  • Thierry Conroy

      Affiliations

    • Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France
  • ,
  • Patrick Schöffski

      Affiliations

    • Hannover Medical School, Hannover, Germany
  • ,
  • Hans Schmoll

      Affiliations

    • Martin Luther Universitaet, Halle, Germany
  • ,
  • Eric Van Cutsem

      Affiliations

    • University Hospital Leuven, Leuven, Belgium
  • ,
  • Claus-Henning Köhne

      Affiliations

    • Klinikum Oldenburg, Oldenburg, Germany

Received 29 June 2005; accepted 5 July 2005.

Abstract 

The purpose of this study was to determine whether baseline patients’ self reported health-related quality of life (HRQOL) parameters could predict survival beyond key biomedical prognostic factors in patients with metastatic colorectal cancer. The analysis was conducted on 299 patients. HRQOL baseline scores were assessed using the European Organisation for Research and Treatment of Cancer, Quality of Life Questionnaire-Core30 (EORTC QLQ-C30). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap resampling technique was used to assess the stability of the outcomes.

The final multivariate Cox regression model retained four variables as independent prognostic factors for survival: white blood cell (WBC) count with a hazard ratio (HR) of 1.961 (95% CI, 1.439–2.672; P<0.001), alkaline phosphatase with HR=1.509 (95% CI, 1.126–2.022; P=0.005), number of sites involved with HR=1.108 (95% CI, 1.024–1.198; P=0.01) and the patient’s score on the social functioning scale with HR=0.991 (95% CI, 0.987–0.996; P<0.001) which translates into a 9% decrease in the patient’s hazard of death for any 10 point increase. The independent prognostic importance of social functioning and the stability of the final Cox regression model were also confirmed by the additional bootstrap model averaging analysis, based on 1000 bootstrap-generated samples. The results suggest that social functioning, acts as a prognostic measure of survival beyond a number of previously known biomedical parameters.

Keywords: Quality of life, Colorectal neoplasms, Prognosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(05)00846-4

doi:10.1016/j.ejca.2005.07.025

Refers to corrigendum:

  • Corrigendum to “Does a patient’s self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?” [Eur. J. Cancer 42 (2006) 42–49]

    Fabio Efficace, Andrew Bottomley, Corneel Coens, Kristel Van Steen, Thierry Conroy, Patrick Schöffski, Hans Schmoll, Eric Van Cutsem, Claus-Henning Köhne
    European Journal of Cancer February 2007 (Vol. 43, Issue 3, Page 633)

European Journal of Cancer
Volume 42, Issue 1 , Pages 42-49, January 2006